Seek Returns logo

FMS vs. THC: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at FMS and THC, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

FMS trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, THC is a standard domestic listing.

SymbolFMSTHC
Company NameFresenius Medical Care AGTenet Healthcare Corporation
CountryGermanyUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Providers & ServicesHealth Care Providers & Services
Market Capitalization14.58 billion USD15.18 billion USD
ExchangeNYSENYSE
Listing DateSeptember 17, 1996March 17, 1980
Security TypeADRCommon Stock

Historical Performance

This chart compares the performance of FMS and THC by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

FMS vs. THC: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolFMSTHC
5-Day Price Return2.02%5.17%
13-Week Price Return-17.32%11.19%
26-Week Price Return-11.70%22.94%
52-Week Price Return20.91%13.46%
Month-to-Date Return-7.06%6.57%
Year-to-Date Return-6.39%36.16%
10-Day Avg. Volume0.64M0.91M
3-Month Avg. Volume0.56M1.62M
3-Month Volatility22.56%37.27%
Beta0.601.53

Profitability

Return on Equity (TTM)

FMS

4.70%

Health Care Providers & Services Industry

Max
26.03%
Q3
13.74%
Median
8.26%
Q1
4.13%
Min
-3.62%

FMS’s Return on Equity of 4.70% is on par with the norm for the Health Care Providers & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.

THC

37.25%

Health Care Providers & Services Industry

Max
26.03%
Q3
13.74%
Median
8.26%
Q1
4.13%
Min
-3.62%

THC’s Return on Equity of 37.25% is exceptionally high, placing it well beyond the typical range for the Health Care Providers & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

FMS vs. THC: A comparison of their Return on Equity (TTM) against the Health Care Providers & Services industry benchmark.

Net Profit Margin (TTM)

FMS

3.36%

Health Care Providers & Services Industry

Max
12.40%
Q3
5.93%
Median
1.96%
Q1
0.93%
Min
-6.10%

FMS’s Net Profit Margin of 3.36% is aligned with the median group of its peers in the Health Care Providers & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

THC

7.17%

Health Care Providers & Services Industry

Max
12.40%
Q3
5.93%
Median
1.96%
Q1
0.93%
Min
-6.10%

A Net Profit Margin of 7.17% places THC in the upper quartile for the Health Care Providers & Services industry, signifying strong profitability and more effective cost management than most of its peers.

FMS vs. THC: A comparison of their Net Profit Margin (TTM) against the Health Care Providers & Services industry benchmark.

Operating Profit Margin (TTM)

FMS

7.57%

Health Care Providers & Services Industry

Max
19.05%
Q3
10.21%
Median
4.22%
Q1
1.98%
Min
-4.27%

FMS’s Operating Profit Margin of 7.57% is around the midpoint for the Health Care Providers & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

THC

17.77%

Health Care Providers & Services Industry

Max
19.05%
Q3
10.21%
Median
4.22%
Q1
1.98%
Min
-4.27%

An Operating Profit Margin of 17.77% places THC in the upper quartile for the Health Care Providers & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

FMS vs. THC: A comparison of their Operating Profit Margin (TTM) against the Health Care Providers & Services industry benchmark.

Profitability at a Glance

SymbolFMSTHC
Return on Equity (TTM)4.70%37.25%
Return on Assets (TTM)2.02%5.11%
Net Profit Margin (TTM)3.36%7.17%
Operating Profit Margin (TTM)7.57%17.77%
Gross Profit Margin (TTM)24.67%82.36%

Financial Strength

Current Ratio (MRQ)

FMS

1.44

Health Care Providers & Services Industry

Max
2.01
Q3
1.49
Median
1.30
Q1
0.94
Min
0.17

FMS’s Current Ratio of 1.44 aligns with the median group of the Health Care Providers & Services industry, indicating that its short-term liquidity is in line with its sector peers.

THC

1.71

Health Care Providers & Services Industry

Max
2.01
Q3
1.49
Median
1.30
Q1
0.94
Min
0.17

THC’s Current Ratio of 1.71 is in the upper quartile for the Health Care Providers & Services industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.

FMS vs. THC: A comparison of their Current Ratio (MRQ) against the Health Care Providers & Services industry benchmark.

Debt-to-Equity Ratio (MRQ)

FMS

0.83

Health Care Providers & Services Industry

Max
2.17
Q3
1.18
Median
0.74
Q1
0.45
Min
0.00

FMS’s Debt-to-Equity Ratio of 0.83 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

THC

3.51

Health Care Providers & Services Industry

Max
2.17
Q3
1.18
Median
0.74
Q1
0.45
Min
0.00

With a Debt-to-Equity Ratio of 3.51, THC operates with exceptionally high leverage compared to the Health Care Providers & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

FMS vs. THC: A comparison of their Debt-to-Equity Ratio (MRQ) against the Health Care Providers & Services industry benchmark.

Interest Coverage Ratio (TTM)

FMS

5.73

Health Care Providers & Services Industry

Max
14.47
Q3
7.15
Median
5.45
Q1
2.04
Min
-4.44

FMS’s Interest Coverage Ratio of 5.73 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.

THC

10.27

Health Care Providers & Services Industry

Max
14.47
Q3
7.15
Median
5.45
Q1
2.04
Min
-4.44

THC’s Interest Coverage Ratio of 10.27 is in the upper quartile for the Health Care Providers & Services industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

FMS vs. THC: A comparison of their Interest Coverage Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Financial Strength at a Glance

SymbolFMSTHC
Current Ratio (MRQ)1.441.71
Quick Ratio (MRQ)1.081.54
Debt-to-Equity Ratio (MRQ)0.833.51
Interest Coverage Ratio (TTM)5.7310.27

Growth

Revenue Growth

FMS vs. THC: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

FMS vs. THC: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

FMS

3.48%

Health Care Providers & Services Industry

Max
5.38%
Q3
2.22%
Median
0.55%
Q1
0.00%
Min
0.00%

With a Dividend Yield of 3.48%, FMS offers a more attractive income stream than most of its peers in the Health Care Providers & Services industry, signaling a strong commitment to shareholder returns.

THC

0.00%

Health Care Providers & Services Industry

Max
5.38%
Q3
2.22%
Median
0.55%
Q1
0.00%
Min
0.00%

THC currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

FMS vs. THC: A comparison of their Dividend Yield (TTM) against the Health Care Providers & Services industry benchmark.

Dividend Payout Ratio (TTM)

FMS

187.56%

Health Care Providers & Services Industry

Max
186.69%
Q3
74.82%
Median
26.76%
Q1
0.00%
Min
0.00%

At 187.56%, FMS’s Dividend Payout Ratio is exceptionally high, exceeding the typical range for the Health Care Providers & Services industry. While this provides a significant return to shareholders, it may limit funds for reinvestment and could be difficult to sustain.

THC

0.00%

Health Care Providers & Services Industry

Max
186.69%
Q3
74.82%
Median
26.76%
Q1
0.00%
Min
0.00%

THC has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

FMS vs. THC: A comparison of their Dividend Payout Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Dividend at a Glance

SymbolFMSTHC
Dividend Yield (TTM)3.48%0.00%
Dividend Payout Ratio (TTM)187.56%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

FMS

18.48

Health Care Providers & Services Industry

Max
55.89
Q3
30.85
Median
21.17
Q1
12.63
Min
0.00

FMS’s P/E Ratio of 18.48 is within the middle range for the Health Care Providers & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

THC

10.24

Health Care Providers & Services Industry

Max
55.89
Q3
30.85
Median
21.17
Q1
12.63
Min
0.00

In the lower quartile for the Health Care Providers & Services industry, THC’s P/E Ratio of 10.24 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

FMS vs. THC: A comparison of their Price-to-Earnings Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Price-to-Sales Ratio (TTM)

FMS

0.62

Health Care Providers & Services Industry

Max
3.10
Q3
1.74
Median
0.67
Q1
0.24
Min
0.00

FMS’s P/S Ratio of 0.62 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

THC

0.73

Health Care Providers & Services Industry

Max
3.10
Q3
1.74
Median
0.67
Q1
0.24
Min
0.00

THC’s P/S Ratio of 0.73 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

FMS vs. THC: A comparison of their Price-to-Sales Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Price-to-Book Ratio (MRQ)

FMS

1.07

Health Care Providers & Services Industry

Max
7.61
Q3
4.32
Median
2.53
Q1
1.14
Min
0.77

FMS’s P/B Ratio of 1.07 is in the lower quartile for the Health Care Providers & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

THC

4.36

Health Care Providers & Services Industry

Max
7.61
Q3
4.32
Median
2.53
Q1
1.14
Min
0.77

THC’s P/B Ratio of 4.36 is in the upper tier for the Health Care Providers & Services industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

FMS vs. THC: A comparison of their Price-to-Book Ratio (MRQ) against the Health Care Providers & Services industry benchmark.

Valuation at a Glance

SymbolFMSTHC
Price-to-Earnings Ratio (TTM)18.4810.24
Price-to-Sales Ratio (TTM)0.620.73
Price-to-Book Ratio (MRQ)1.074.36
Price-to-Free Cash Flow Ratio (TTM)6.026.86